Abstract
We report herein, the histological observations taken at initial laparotomy from a 55 year old man with unresectable gastric cancer who responded almost completely to chemotherapy with Etoposide/Adriamycin/Cisplatin (EAP). The patient underwent a second operation after 2 cycles of EAP therapy and the stomach and adjacent lymph nodes were successfully resected. Histologic findings showed that cancer cells in the main tumor including the site of direct invasion had completely disappeared and been replaced by regenerated mucosa. The metastatic lymph node tumor was also partially killed, as indicated by a cluster of viable cancer cells which was divided by a strip of necrotic tissue. These findings led us to conclude that EAP therapy was remarkably effective for the patient.
Similar content being viewed by others
References
Preusser P, Wilke H, Achterrath W, Neuhaus B, Balleisen L, Meyer J, Vandeloo J. Advanced inoperable stomach cancer: a pilot study with the combination Etoposide, Adriamycin and Cisplatin. Anticancer Res 1986; 6: 1195–1196.
Preusser P, Wilke H, Achterrath W, Fink U, Meyer J, Meyer HG, Loo J. Phase-II-Studie mit Etoposid, Adriamycin, Cisplatin (EAP) beim primaer inoperablen, metastasierten Magenkarzinom. Tumor Diagnostik & Therapie 1987; 8: 43–48.
Comis RL, Carter SK. A review of chemotherapy in gastric cancer. Cancer 1974; 34: 1576–1586.
Moertel CG, Lavin PT. Phase II–III chemotherapy studies in advanced gastric cancer. Cancer Treat Rep 1979; 63: 1863–1869.
Lawrence L, McDonald B, Dindogru A, Samson M, Vaitkevicius VK. Cisplatin—An active drug in the treatment of disseminated gastric cancer. Cancer 1984; 53: 18–22.
Kelsen DP, Magill GB, Cheng E, Dukeman M, Sordillo P, Heelan R, Yagoda A. Phase II trial of etoposide in adenocarcinoma of the gastrointestinal tract. Cancer Treatment Reports 1983; 67: 509–510.
Vogl SE, Engstrom PF. Cisplatin, doxorubicin, and 5-FU in combination for advanced gastric cancer. Cancer Treat Rep 1984; 68: 1273–1275.
Wegenar DJ, Yap SH, Wobbes T, Burghous JTM, Dam FE, Hillen HFP, Hoogendoorn GJ, Scheerder H, Vegt SGL. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol 1985; 15: 86–87.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tahara, H., Ogawa, M., Kido, Y. et al. The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer —Report of a histologically proven case—. The Japanese Journal of Surgery 21, 433–437 (1991). https://doi.org/10.1007/BF02470971
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470971